About Us
Overview
Management
Scientific Advisory Board
Partnership Opportunities
News release
Technology
Vaccines
Diagnostics
Drug Delivery
Separation Science
Customer Services
Bio-Pharmaceuticals
Conjugation Chemistry
Products
Pipeline
Reagents & Chemicals
Formulations
Specialized in
 
Business planning and development
 
 
Protein Therapeutics and Diagnostics
 
 
Conjugation Chemistry
 
 
Novel Drug Delivery Systems
 
Location Study Participation Advantages Investors Careers Contact Us

Imaging agents

We have expertise in flexible ‘Click chemistry’ is to develop radioisotopes and fluorescent probes for positron emission tomography (PET),SPECT, MRI, optical imaging agents in personalized medicine and drug development that provide high quality images.

Services

  • Conjugating one or more complexing agents with a targeting moiety, such as natural amino acids, unnatural amino acids, peptides, peptide nucleic acids, nucleotides, and analogs and derivatives thereof.
  • The probe of interest is first conjugated to a chelating agent that is able to form stable complexes with the radionuclide/fluorescent of interest. This conjugation step can be carried out as part of the solid-phase synthesis, or it can be undertaken in the solution phase after synthesis and purification of the probe.
  • The probe of choice can be labeled with radiometals such as Tc-99m, In-111, Rh-105, and Cu-64 with development of bioclearance agents for achieving radioactivity clearance from non-target organs.

 
About Us | Products | Customer Services | Technology | Location | Study Participation | Advantages | Investors | Careers | Contact Us
Copyright © Bioonco 2006 All Rights Reserved